Clinical trials
Phase 1 trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
651 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 2 |
| 2003 | 3 |
| 2004 | 6 |
| 2005 | 6 |
| 2006 | 14 |
| 2007 | 23 |
| 2008 | 16 |
| 2009 | 30 |
| 2010 | 20 |
| 2011 | 41 |
| 2012 | 21 |
| 2013 | 32 |
| 2014 | 30 |
| 2015 | 26 |
| 2016 | 39 |
| 2017 | 36 |
| 2018 | 27 |
| 2019 | 32 |
| 2020 | 31 |
| 2021 | 43 |
| 2022 | 47 |
| 2023 | 34 |
| 2024 | 51 |
| 2025 | 20 |
| 2026 | 18 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 332 |
| Terminated | 114 |
| Active, not recruiting | 81 |
| Recruiting | 76 |
| Unknown status | 30 |
| Withdrawn | 10 |
| Not yet recruiting | 4 |
| Enrolling by invitation | 2 |
| Suspended | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 88 |
| Hoffmann-La Roche | 43 |
| GlaxoSmithKline | 23 |
| Incyte Corporation | 20 |
| Eli Lilly and Company | 16 |
| Pfizer | 15 |
| AbbVie | 14 |
| Amgen | 13 |
| Bayer | 13 |
| Bristol-Myers Squibb | 13 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Non-Small-Cell Lung | 71 |
| Neoplasms | 70 |
| Breast Neoplasms | 44 |
| Colorectal Neoplasms | 41 |
| Lymphoma, Non-Hodgkin | 40 |
| Melanoma | 33 |
| Neoplasm Metastasis | 33 |
| Multiple Myeloma | 30 |
| Recurrence | 29 |
| Lymphoma, Large B-Cell, Diffuse | 27 |
Trials
Showing 1 to 25 of 651. Each trial links to its page on Pharma Observatory.
551 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.